Nifty
Sensex
:
:
10799.65
36674.52
36.00 (0.33%)
187.24 (0.51%)

Pharmaceuticals & Drugs - Global

Rating :
60/99  (View)

BSE: 532649 | NSE: NECLIFE

22.30
-0.50 (-2.19%)
07-Jul-2020 | 3:55PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  23.20
  •  23.25
  •  22.20
  •  22.80
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  434913
  •  96.99
  •  30.05
  •  7.10

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 511.32
  • 12.27
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,393.44
  • 0.22%
  • 0.45

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 55.80%
  • 16.94%
  • 21.57%
  • FII
  • DII
  • Others
  • 2.9%
  • 0.00%
  • 2.79%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 12.66
  • 11.12
  • 19.22

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 3.07
  • -0.23
  • 3.31

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -6.43
  • -6.51
  • -4.96

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 10.84
  • 11.99
  • 9.91

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 0.28
  • 0.28
  • 0.28

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 5.44
  • 5.94
  • 5.48

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Jun 19
Jun 18
Var%
Net Sales
0
0
0
648
733
-12%
579
724
-20%
639
593
8%
Expenses
0
0
0
592
667
-11%
531
659
-20%
577
533
8%
EBITDA
0
0
0
56
65
-14%
48
64
-26%
62
60
3%
EBIDTM
0%
0%
8%
8%
7%
8%
10%
10%
Other Income
0
0
0
1
2
-62%
1
1
-18%
2
1
63%
Interest
0
0
0
31
36
-14%
33
44
-25%
31
30
5%
Depreciation
0
0
0
15
17
-10%
14
16
-11%
16
16
1%
PBT
0
0
0
10
14
-26%
3
7
-62%
16
15
7%
Tax
0
0
0
2
3
-32%
0
1
-83%
3
2
29%
PAT
0
0
0
8
11
-25%
2
6
-58%
14
13
3%
PATM
0%
0%
1%
1%
0%
1%
2%
2%
EPS
0.00
0.00
0
0.46
0.61
-25%
0.14
0.33
-58%
0.77
0.74
4%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Net Sales
-
2,783
1,876
1,644
1,676
1,644
1,638
1,626
1,313
1,062
846
Net Sales Growth
-
48%
14%
-2%
2%
0%
1%
24%
24%
26%
 
Cost Of Goods Sold
-
2,218
1,367
1,154
1,174
1,141
1,155
1,142
907
711
544
Gross Profit
-
565
509
489
502
502
484
484
406
351
301
GP Margin
-
20%
27%
30%
30%
31%
30%
30%
31%
33%
36%
Total Expenditure
-
2,519
1,640
1,419
1,437
1,377
1,350
1,336
1,065
835
651
Power & Fuel Cost
-
103
92
75
88
80
66
61
42
34
29
% Of Sales
-
4%
5%
5%
5%
5%
4%
4%
3%
3%
3%
Employee Cost
-
77
75
76
78
59
48
46
44
34
29
% Of Sales
-
3%
4%
5%
5%
4%
3%
3%
3%
3%
3%
Manufacturing Exp.
-
50
53
53
40
37
34
34
30
24
13
% Of Sales
-
2%
3%
3%
2%
2%
2%
2%
2%
2%
2%
General & Admin Exp.
-
22
23
20
20
22
22
18
17
13
18
% Of Sales
-
1%
1%
1%
1%
1%
1%
1%
1%
1%
2%
Selling & Distn. Exp.
-
46
29
39
35
35
25
30
18
15
14
% Of Sales
-
2%
2%
2%
2%
2%
2%
2%
1%
1%
2%
Miscellaneous Exp.
-
3
2
2
1
3
1
5
7
4
14
% Of Sales
-
0%
0%
0%
0%
0%
0%
0%
1%
0%
0%
EBITDA
-
264
236
224
239
267
288
290
249
227
195
EBITDA Margin
-
9%
13%
14%
14%
16%
18%
18%
19%
21%
23%
Other Income
-
6
6
23
6
20
13
16
13
13
19
Interest
-
148
115
117
123
126
138
115
115
74
60
Depreciation
-
63
64
62
57
77
84
76
61
46
39
PBT
-
59
63
67
64
85
78
115
85
120
115
Tax
-
11
10
12
10
18
16
29
12
16
23
Tax Rate
-
19%
17%
18%
15%
22%
21%
25%
14%
13%
20%
PAT
-
48
52
55
54
66
62
86
73
104
92
PAT before Minority Interest
-
48
52
55
54
66
62
86
73
104
92
Minority Interest
-
0
0
0
0
0
0
0
0
0
0
PAT Margin
-
2%
3%
3%
3%
4%
4%
5%
6%
10%
11%
PAT Growth
-
-9%
-6%
2%
-18%
7%
-28%
17%
-30%
13%
 
EPS
-
2.67
2.93
3.10
3.04
3.72
3.48
4.81
4.11
5.84
5.18

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Shareholder's Funds
1,105
1,059
1,007
954
958
927
868
784
721
621
Share Capital
22
22
22
22
22
22
22
22
22
22
Total Reserves
1,083
1,036
984
932
936
905
845
762
699
598
Non-Current Liabilities
300
356
296
362
397
341
362
432
289
651
Secured Loans
164
218
161
243
264
223
260
363
234
451
Unsecured Loans
1
2
3
2
1
1
0
1
1
150
Long Term Provisions
9
9
8
7
6
5
4
3
2
0
Current Liabilities
1,300
1,309
1,279
1,240
1,156
1,126
1,045
904
803
209
Trade Payables
531
539
528
497
456
440
383
194
140
135
Other Current Liabilities
123
123
107
108
90
87
131
130
246
9
Short Term Borrowings
636
634
630
627
595
580
509
565
330
0
Short Term Provisions
10
12
13
8
14
19
22
15
87
65
Total Liabilities
2,705
2,724
2,581
2,556
2,510
2,394
2,274
2,121
1,813
1,480
Net Block
825
852
881
906
934
948
914
858
736
627
Gross Block
1,490
1,456
1,364
1,384
1,451
1,341
1,223
1,091
909
754
Accumulated Depreciation
666
604
482
478
518
394
309
234
173
127
Non Current Assets
1,036
1,063
1,085
1,092
1,106
1,157
1,123
1,071
869
683
Capital Work in Progress
100
100
102
99
91
122
139
150
82
56
Non Current Investment
0
0
0
0
0
0
0
0
0
0
Long Term Loans & Adv.
108
104
97
82
80
87
70
63
50
0
Other Non Current Assets
3
7
5
4
0
0
0
0
0
0
Current Assets
1,669
1,661
1,496
1,464
1,369
1,237
1,151
1,050
944
798
Current Investments
1
1
0
1
0
0
0
0
5
21
Inventories
918
859
855
837
791
758
676
591
471
396
Sundry Debtors
559
612
500
491
446
377
349
304
311
222
Cash & Bank
21
9
13
37
33
10
6
26
33
35
Other Current Assets
170
55
54
32
98
92
119
128
124
123
Short Term Loans & Adv.
99
125
74
68
85
69
87
105
102
97
Net Current Assets
369
351
217
224
213
111
106
145
141
589
Total Assets
2,705
2,724
2,581
2,556
2,510
2,394
2,274
2,121
1,813
1,480

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Cash From Operating Activity
239
65
199
169
144
255
361
165
44
55
PBT
59
63
67
65
85
78
115
85
120
115
Adjustment
207
176
159
174
185
213
180
157
122
84
Changes in Working Capital
-13
-161
-20
-62
-119
-16
68
-64
-186
-132
Cash after chg. in Working capital
253
78
206
177
151
275
363
178
56
68
Interest Paid
0
0
0
0
0
0
0
0
0
0
Tax Paid
-14
-13
-7
-9
-6
-20
-2
-13
-13
-12
Other Direct Exp. Paid
0
0
0
0
0
0
0
0
0
0
Extra & Other Items
0
0
0
0
0
0
0
0
0
0
Cash From Investing Activity
-26
-29
-18
-77
-60
-90
-99
-234
-169
-146
Net Fixed Assets
-34
-90
17
60
-79
-102
-120
-250
-182
-121
Net Investments
0
0
0
-1
0
0
0
5
20
-20
Others
8
61
-35
-136
20
12
22
11
-7
-4
Cash from Financing Activity
-201
-40
-204
-89
-61
-161
-282
62
123
91
Net Cash Inflow / Outflow
12
-4
-23
3
23
4
-20
-7
-2
0
Opening Cash & Equivalents
9
13
37
33
10
6
26
33
35
34
Closing Cash & Equivalent
21
9
13
37
33
10
6
26
33
35

Financial Ratios

Consolidated /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Book Value (Rs.)
49
47
45
43
41
41
39
35
32
28
ROA
2%
2%
2%
2%
3%
3%
4%
4%
6%
7%
ROE
4%
5%
6%
6%
7%
7%
10%
10%
16%
20%
ROCE
10%
9%
10%
10%
12%
12%
13%
12%
14%
16%
Fixed Asset Turnover
2.11
1.48
1.27
1.26
1.25
1.33
1.45
1.35
1.35
1.29
Receivable days
69
97
104
95
86
78
71
83
87
80
Inventory Days
104
149
177
166
162
153
138
143
141
154
Payable days
72
114
128
119
113
106
76
55
56
85
Cash Conversion Cycle
101
132
153
142
134
125
133
172
172
149
Total Debt/Equity
0.82
0.90
0.87
1.01
1.00
0.93
1.01
1.33
1.10
0.97
Interest Cover
1
2
2
2
2
2
2
2
3
3

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.